About this trial

The study aims to evaluate and compare the incidence of atrial arrhythmias (including Post-Operative Atrial Fibrillation (POAF), atrial flutter, and atrial tachycardia) stratified by baseline Utah fibrosis stages and overall fibrosis (%) of the left atrial wall area. The investigators hypothesize that patients with a higher baseline Utah fibrosis staging will experience a higher incidence of POAF.

The study also aims to evaluate and compare the in-hospital mortality, length-of-stay (LOS), complication rates (strokes, pneumonia, respiratory failure etc.) of the different Utah fibrosis stage cohorts. Perform cost analysis and compare between patients with POAF and patients without POAF. The investigators hypothesize that patients experiencing POAF will have a higher mortality rate, longer LOS, greater complications, and therefore, additional hospital costs.

Eligibility criteria

Qualifiers

Male or female patients age 40 years of age or older

Patients with no history of atrial arrhythmia (atrial fibrillation, atrial flutter, atrial tachycardia) scheduled to undergo cardiac surgery (These surgeries include but are not limited to coronary artery bypass graft (CABG), valvular repair/reconstruction, aneurysm repair, and insertion of pacemaker).

Disqualifiers

Patients with a history of atrial arrhythmia (atrial fibrillation, atrial flutter, atrial tachycardia)

Patients with a history of cardiac or open chest surgery

Patients with a history of catheter ablation

Patients under the age of 40

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Locations

3
Lakeview Hospital70433, CovingtonLouisiana, United States
East Jefferson General Hospital70006, New OrleansLouisiana, United States
Washington University Barnes-Jewish Hospital63110, St LouisMissouri, United States

Sponsors and collaborators

Tulane University

Lead sponsor